Preclinical efficacy of targeting epigenetic mechanisms in AML with 3q26 lesions and EVI1 overexpression

Name: Preclinical efficacy of targeting epigenetic mechanisms in AML with 3q26 lesions and EVI1 overexpression
Published: 2025-06-04T00:00:00+08:00

NIAID Data Ecosystem2026-05-02 收录

急性髓系白血病表观遗传靶向治疗

AML3q26/EVI1临床前药效

数据链接：

https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE247095 数据链接链接失效反馈

官方服务：

资源简介：

This SuperSeries is composed of the SubSeries listed below. Refer to individual Series

创建时间：

2025-06-04

Preclinical efficacy of targeting epigenetic mechanisms in AML with 3q26 lesions and EVI1 overexpression

资源简介：

相关数据集